Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on May 5, 2015, reporting events occurring on May 1, 2015. The filing addresses Item 8.01 (Other Events) regarding senior management appointments in commercialization and manufacturing. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as "Second Sight Medical Products, Inc."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the restructuring of senior leadership roles:
- Departure: Brian Mech, former Vice President of Business Development, left the company on April 30, 2015, to pursue other opportunities.
- Appointments:
- Anthony Moses appointed as Commercial Vice President, Americas.
- James Miller appointed as Director of Manufacturing.
- Transition: Anthony Moses assumed the responsibilities previously held by Brian Mech. Brian Mech agreed to provide consulting services on an as-needed basis through April 2016.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on future performance, or specific risk factors. The document serves solely to disclose the management appointments and the departure of a former executive.
Key Facts for Investor Verification
- Verify the exact date of Brian Mech's departure (April 30, 2015) and the terms of his consulting agreement through April 2016.
- Confirm the specific scope of Anthony Moses' new role as Commercial Vice President, Americas, particularly regarding the transition of Business Development duties.
- Review the background of James Miller to assess his fit for the Director of Manufacturing role, given his experience with Boston Scientific and neuromodulator manufacturing.
- Check subsequent filings for any financial impact related to these personnel changes or the departure of the former VP of Business Development.